Recklessness Claim Can Be Filed In Generic Warning Label Case, State Court Says

(March 16, 2018, 2:00 PM EDT) -- BOSTON — The Massachusetts Supreme Judicial Court on March 16 vacated the dismissal of a Proscar (finasteride) claim against Merck & Co. Inc., ruling that the plaintiff can amend his complaint to bring a common-law recklessness claim against Merck for allegedly failing to update the drug label to warn of a risk of permanent impotency cause by the generic version of the drug (Brian Rafferty v. Merck & Co., Inc., et al., No. AJC-12347, Mass. Sup.)....

Attached Documents

Related Sections